Volume 1, Issue 7: Role of GLP-1 Receptor Agonists in the Treatment Continuum of Type 2 Diabetes

e-Diabetes Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with diabetes. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.

(Volume 1, Issue 7)

 

Target Audience

Nurses and health care professionals involved in the care of patients with diabetes.

Learning Objectives

After participating in this activity, the participant will demonstrate the ability to: 

  • Describe appropriate patients for GLP-1 agonist therapy.
  • Explain how GLP-1 agonists can be used effectively in place of or along with basal insulin.
  • Discuss how current data do not support concerns about the pancreatic safety of GLP-1 agonists.
Additional information
Contact email: 
[email protected]
Course summary
Available credit: 
  • 1.00 ANCC
Registration opens: 
09/25/2014
Registration closes: 
09/24/2016
Cost:
$0.00
Rajesh Garg, MD
Assistant Professor of Medicine
Harvard Medical School
Associate Physician, Division of Endocrinology, Diabetes and Hypertension
Brigham and Women’s Hospital
Boston, Massachusetts
 

Available Credit

  • 1.00 ANCC

Price

Cost:
$0.00
Please login or register to take this course.